科研之友
微信
新浪微博
Facebook
分享链接
摘要
There are several studies carried out to test the effect of cholestasis on memory impairment and anxiolytic-like behaviors. Some previous studies have shown that cholestasis alters the activity of opioidergic and dopaminergic systems. The aim of the present study is however to investigate the role of mu opioid, D-1 and D-2 dopamine ventral hippocampal (CA(3)) receptors upon cholestasis-induced anxiolytic-like behaviors in hole board task. Male mice weighing 25-30 g were used. Cholestasis was induced by ligation of the main bile duct. Our data indicated that cholestasis can induce anxiolytic-like response. Furthermore, the results showed that the intra-CA(3) injection of naloxone, a mu receptor antagonist at 025 and 0.5 mu g/mouse, SCH23390, a D-1 dopamine receptor antagonist or sulpiride, as a D-2 dopamine receptor antagonist, 5 min before testing, reversed the cholestasis-induced anxiolytic-like behaviors seven days after bile duct ligation (BDL). Unlike the higher dose of SCH23390 (0.5 mu g/mouse) which induced anxiogenic-like behaviors, other doses of the above drugs did not alter the exploratory behaviors in examined mice. Based on our findings, co-administration of the subthreshold dose of naloxone (0.125 mu g/mouse), SCH23390 or sulpiride, and SCH23390 with sulpiride, neither altered exploratory behaviors in animals nor reversed the cholestasis-induced anxiolytic-like behaviors, seven days post BDL. Current results demonstrated firstly, the anxiolytic-like behaviors are evident in cholestatic mice seven days post BDL; secondly, there are plausible mechanisms governing the involvement of the CA(3) opioidergic and dopaminergic systems in this phenomenon and thirdly, there seem to be no interaction between these systems.
- 出版日期2013-8-15
